NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome

Alessandro De Luca, Irene Bottillo, Anna Sarkozy, Claudio Carta, Cinzia Neri, Emanuele Bellacchio, Annalisa Schirinzi, Emanuela Conti, Giuseppe Zampino, Agatino Battaglia, Silvia Majore, Maria M. Rinaldi, Massimo Carella, Bruno Marino, Antonio Pizzuti, Maria Cristina Digilio, Marco Tartaglia, Bruno Dallapiccola

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Neurofibromatosis type 1 (NF1) demonstrates phenotypic overlap with Noonan syndrome (NS) in some patients, which results in the so-called neurofibromatosis-Noonan syndrome (NFNS). From a genetic point of view, NFNS is a poorly understood condition, and controversy remains as to whether it represents a variable manifestation of either NF1 or NS or is a distinct clinical entity. To answer this question, we screened a cohort with clinically well-characterized NFNS for mutations in the entire coding sequence of the NF1 and PTPN11 genes. Heterozygous NF1 defects were identified in 16 of the 17 unrelated subjects included in the study, which provides evidence that mutations in NF1 represent the major molecular event underlying this condition. Lesions included nonsense mutations, out-of-frame deletions, missense changes, small inframe deletions, and one large multiexon deletion. Remarkably, a high prevalence of inframe defects affecting exons 24 and 25, which encode a portion of the GAP-related domain of the protein, was observed. On the other hand, no defect in PTPN11 was observed, and no lesion affecting exons 11-27 of the NF1 gene was identified in 100 PTPN11 mutation-negative subjects with NS, which provides further evidence that NFNS and NS are genetically distinct disorders. These results support the view that NFNS represents a variant of NF1 and is caused by mutations of the NF1 gene, some of which have been demonstrated to cause classic NF1 in other individuals.

Original languageEnglish
Pages (from-to)1092-1101
Number of pages10
JournalAmerican Journal of Human Genetics
Volume77
Issue number6
DOIs
Publication statusPublished - Dec 2005

Fingerprint

Neurofibromatosis 1 Genes
Neurofibromatosis 1
Noonan Syndrome
Mutation
Exons
Neurofibromatosis-Noonan syndrome
Frameshift Mutation
Neurofibromatoses
Nonsense Codon

ASJC Scopus subject areas

  • Genetics

Cite this

NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. / De Luca, Alessandro; Bottillo, Irene; Sarkozy, Anna; Carta, Claudio; Neri, Cinzia; Bellacchio, Emanuele; Schirinzi, Annalisa; Conti, Emanuela; Zampino, Giuseppe; Battaglia, Agatino; Majore, Silvia; Rinaldi, Maria M.; Carella, Massimo; Marino, Bruno; Pizzuti, Antonio; Digilio, Maria Cristina; Tartaglia, Marco; Dallapiccola, Bruno.

In: American Journal of Human Genetics, Vol. 77, No. 6, 12.2005, p. 1092-1101.

Research output: Contribution to journalArticle

De Luca, A, Bottillo, I, Sarkozy, A, Carta, C, Neri, C, Bellacchio, E, Schirinzi, A, Conti, E, Zampino, G, Battaglia, A, Majore, S, Rinaldi, MM, Carella, M, Marino, B, Pizzuti, A, Digilio, MC, Tartaglia, M & Dallapiccola, B 2005, 'NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome', American Journal of Human Genetics, vol. 77, no. 6, pp. 1092-1101. https://doi.org/10.1086/498454
De Luca, Alessandro ; Bottillo, Irene ; Sarkozy, Anna ; Carta, Claudio ; Neri, Cinzia ; Bellacchio, Emanuele ; Schirinzi, Annalisa ; Conti, Emanuela ; Zampino, Giuseppe ; Battaglia, Agatino ; Majore, Silvia ; Rinaldi, Maria M. ; Carella, Massimo ; Marino, Bruno ; Pizzuti, Antonio ; Digilio, Maria Cristina ; Tartaglia, Marco ; Dallapiccola, Bruno. / NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. In: American Journal of Human Genetics. 2005 ; Vol. 77, No. 6. pp. 1092-1101.
@article{8ae74ee15aaf4153bb8feb68b9cdd4fb,
title = "NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome",
abstract = "Neurofibromatosis type 1 (NF1) demonstrates phenotypic overlap with Noonan syndrome (NS) in some patients, which results in the so-called neurofibromatosis-Noonan syndrome (NFNS). From a genetic point of view, NFNS is a poorly understood condition, and controversy remains as to whether it represents a variable manifestation of either NF1 or NS or is a distinct clinical entity. To answer this question, we screened a cohort with clinically well-characterized NFNS for mutations in the entire coding sequence of the NF1 and PTPN11 genes. Heterozygous NF1 defects were identified in 16 of the 17 unrelated subjects included in the study, which provides evidence that mutations in NF1 represent the major molecular event underlying this condition. Lesions included nonsense mutations, out-of-frame deletions, missense changes, small inframe deletions, and one large multiexon deletion. Remarkably, a high prevalence of inframe defects affecting exons 24 and 25, which encode a portion of the GAP-related domain of the protein, was observed. On the other hand, no defect in PTPN11 was observed, and no lesion affecting exons 11-27 of the NF1 gene was identified in 100 PTPN11 mutation-negative subjects with NS, which provides further evidence that NFNS and NS are genetically distinct disorders. These results support the view that NFNS represents a variant of NF1 and is caused by mutations of the NF1 gene, some of which have been demonstrated to cause classic NF1 in other individuals.",
author = "{De Luca}, Alessandro and Irene Bottillo and Anna Sarkozy and Claudio Carta and Cinzia Neri and Emanuele Bellacchio and Annalisa Schirinzi and Emanuela Conti and Giuseppe Zampino and Agatino Battaglia and Silvia Majore and Rinaldi, {Maria M.} and Massimo Carella and Bruno Marino and Antonio Pizzuti and Digilio, {Maria Cristina} and Marco Tartaglia and Bruno Dallapiccola",
year = "2005",
month = "12",
doi = "10.1086/498454",
language = "English",
volume = "77",
pages = "1092--1101",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome

AU - De Luca, Alessandro

AU - Bottillo, Irene

AU - Sarkozy, Anna

AU - Carta, Claudio

AU - Neri, Cinzia

AU - Bellacchio, Emanuele

AU - Schirinzi, Annalisa

AU - Conti, Emanuela

AU - Zampino, Giuseppe

AU - Battaglia, Agatino

AU - Majore, Silvia

AU - Rinaldi, Maria M.

AU - Carella, Massimo

AU - Marino, Bruno

AU - Pizzuti, Antonio

AU - Digilio, Maria Cristina

AU - Tartaglia, Marco

AU - Dallapiccola, Bruno

PY - 2005/12

Y1 - 2005/12

N2 - Neurofibromatosis type 1 (NF1) demonstrates phenotypic overlap with Noonan syndrome (NS) in some patients, which results in the so-called neurofibromatosis-Noonan syndrome (NFNS). From a genetic point of view, NFNS is a poorly understood condition, and controversy remains as to whether it represents a variable manifestation of either NF1 or NS or is a distinct clinical entity. To answer this question, we screened a cohort with clinically well-characterized NFNS for mutations in the entire coding sequence of the NF1 and PTPN11 genes. Heterozygous NF1 defects were identified in 16 of the 17 unrelated subjects included in the study, which provides evidence that mutations in NF1 represent the major molecular event underlying this condition. Lesions included nonsense mutations, out-of-frame deletions, missense changes, small inframe deletions, and one large multiexon deletion. Remarkably, a high prevalence of inframe defects affecting exons 24 and 25, which encode a portion of the GAP-related domain of the protein, was observed. On the other hand, no defect in PTPN11 was observed, and no lesion affecting exons 11-27 of the NF1 gene was identified in 100 PTPN11 mutation-negative subjects with NS, which provides further evidence that NFNS and NS are genetically distinct disorders. These results support the view that NFNS represents a variant of NF1 and is caused by mutations of the NF1 gene, some of which have been demonstrated to cause classic NF1 in other individuals.

AB - Neurofibromatosis type 1 (NF1) demonstrates phenotypic overlap with Noonan syndrome (NS) in some patients, which results in the so-called neurofibromatosis-Noonan syndrome (NFNS). From a genetic point of view, NFNS is a poorly understood condition, and controversy remains as to whether it represents a variable manifestation of either NF1 or NS or is a distinct clinical entity. To answer this question, we screened a cohort with clinically well-characterized NFNS for mutations in the entire coding sequence of the NF1 and PTPN11 genes. Heterozygous NF1 defects were identified in 16 of the 17 unrelated subjects included in the study, which provides evidence that mutations in NF1 represent the major molecular event underlying this condition. Lesions included nonsense mutations, out-of-frame deletions, missense changes, small inframe deletions, and one large multiexon deletion. Remarkably, a high prevalence of inframe defects affecting exons 24 and 25, which encode a portion of the GAP-related domain of the protein, was observed. On the other hand, no defect in PTPN11 was observed, and no lesion affecting exons 11-27 of the NF1 gene was identified in 100 PTPN11 mutation-negative subjects with NS, which provides further evidence that NFNS and NS are genetically distinct disorders. These results support the view that NFNS represents a variant of NF1 and is caused by mutations of the NF1 gene, some of which have been demonstrated to cause classic NF1 in other individuals.

UR - http://www.scopus.com/inward/record.url?scp=28144437387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28144437387&partnerID=8YFLogxK

U2 - 10.1086/498454

DO - 10.1086/498454

M3 - Article

VL - 77

SP - 1092

EP - 1101

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 6

ER -